The Research and Development team at Promentis Pharmaceuticals is responsible for driving innovative research to discover and develop novel antipsychotic medications. This team collaborates closely across scientific disciplines to design and conduct preclinical and clinical trials, ensuring the safety and efficacy of new treatments for schizophrenia. Their efforts are pivotal in advancing therapeutic options and improving patient outcomes.